News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BIND Therapeutics to Present at the Credit Suisse 2013 Healthcare Conference



11/4/2013 6:44:06 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the Credit Suisse 2013 Healthcare Conference in Phoenix, Arizona on Wednesday, November 13, 2013 at 3:30 p.m. MST.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES